Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Deciphering the molecular architecture of inflammatory bowel disease and other common complex diseases. Michel Georges Unit of Animal Genomics GIGA-R & Faculty of Veterinary Medicine University of Liège Inflammatory Bowel Disease Burril Bernard Crohn, 1921 Mount Sinai Hospital, NY 0.15% Environmentally triggered, yet highly heritable Schreiber S, Rosenstiel P, Albrecht M, Hampe J, Krawczak M. Genetics of Crohn disease, an archetypal inflammatory barrier disease. Nat Rev Genet. 2005 May;6(5):376-88. Identifying susceptibility variants: why? Understanding pathogenesis Identifying novel drug targets Predictive, personalized medicine (?) How? Positional cloning Polymorphism How? Positional cloning Linkage How? Positional cloning Linkage disequilibrium How? Positional cloning Originally a three step process Mapping linkage Fine-mapping LD Identifying causal variants and genes NOD2, archetypal example of successfull positional cloning A long and winding road … The “GWAS” concept Risch & Merikangas, Science 273:1516 (1996) Enabling GWAS HapMap Common SNPs Enabling GWAS Illumina & Affymetrix “Breakthrough of the year” 2007 Inflammatory Bowel Disease Rich harvest … Barret et al. 2008 Franke et al. 2010 Locus ≠ gene ≠ variant New insights in pathogenesis Pervasive “pleiotropy” Limited variance explained Limited variance explained … Missing heritability issue Overestimated heritabilities Incomplete genome coverage Structural variants Incomplete LD between SNPs and causative variants “Imputation” In silico genotype imputation Highly penetrant rare variants not tagged by common SNPs Highly penetrant rare variants not tagged by common SNPs (Nature 411: 599-603 2001.) 5% 17% Quasi-infinitesimal architecture GxG interactions or epistasis Non-Mendelian modes of inheritance Perspectives GWAS will continue to yield import pathogenic insights Small RR don’t preclude large pharmacological effects Genome-wide RR will be computable soon, with putative utility for society and the individual … Acknowledgments ULg E. Louis & J. Belaiche C. Libioulle S. Hansoul C. Sandor Y. Momozawa M. Mni ULB, KUL, RUG, UCL D. Franchimont, S. Vermeire, M. De Vos, O. Dewit CNG, INSERM M. Lathrop, J-P Hugot RW - DGTRE FNRS Politique Scientifique Fédérale (PAI)